๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Silent cirrhosis in patients with hepatocellular carcinoma. Implications for screening in high-incidence and low-incidence areas

โœ Scribed by S. N. Zaman; P. J. Johnson; Roger Williams

Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
417 KB
Volume
65
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Rate of incidence of hepatocellular carc
Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis
โœ Maria Chiaramonte; Tommaso Stroffolini; Alfredo Vian; Maria Antonia Stazi; Annar ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 83 KB ๐Ÿ‘ 2 views

## BACKGROUND. Cirrhosis of viral etiology due to hepatitis B virus (HBV) or hepatitis C virus (HCV) infection is a risk factor for hepatocellular carcinoma (HCC). The current study evaluated the rate of incidence of HCC in patients with compensated cirrhosis of viral etiology.

Varying incidence of cirrhosis and hepat
Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy
โœ Michiko Shindo; Arai Ken; Tadao Okuno ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 92 KB ๐Ÿ‘ 2 views

## BACKGROUND. To determine whether interferon (IFN) therapy can reduce incidence of the development of cirrhosis and hepatocellular carcinoma equally in patients with chronic hepatitis C virus (HCV) who responded differently to therapy, a retrospective analysis of 250 patients treated with IFN wa

Association between high serum alanine a
Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis
โœ Kazuo Tarao; Yasushi Rino; Shinichi Ohkawa; Akio Shimizu; Setsuo Tamai; Kaoru Mi ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 151 KB ๐Ÿ‘ 2 views

Many studies have demonstrated in animal experiments that persistent inflammation may accelerate the development of carcinoma. In this article, the question of whether the persistent elevation of serum alanine aminotransferase (ALT) levels (which represents the inflammatory necrosis of hepatocytes)